Found 21 matching trials
ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon PHASE2 The trial is a single-centre, randomised, sequential, cross-over trial asse...
Show More Location
Profil Institut für Stoffwechselforschung GmbH
Learn More & Join Trial
Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents PHASE1 This study will be looking to confirm the effect of dasiglucagon when compa...
Show More Learn More & Join Trial
Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes PHASE2 The aim of the study is to compare the efficacy of low-dose dasiglucagon (Z...
Show More Location
Steno Diabetes Center Copenhagen
Learn More & Join Trial
A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM PHASE3 A randomized, double-blind, crossover trial to compare the efficacy and saf...
Show More Location
LMC Diabetes & Manna Research
Learn More & Join Trial
A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism PHASE3 The objective of the trial is to evaluate the efficacy and safety of dasigl...
Show More Location
Children's Hospital of Colorado
Learn More & Join Trial
Treatment of Post-bariatric Hypoglycaemia PHASE2 This is an investigator-initiated, proof-of-concept, randomised, double-bli...
Show More Location
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Learn More & Join Trial
Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes PHASE2 The aim of the study is to evaluate the efficacy, safety and feasibility of...
Show More Location
Steno Diabetes Center Copenhagen
Learn More & Join Trial
Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass PHASE2 The aim of this study is investigating the effect of a novel glucagon analo...
Show More Location
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Learn More & Join Trial
A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System PHASE2 The main objective is to determine the feasibility of dasiglucagon in a bi-...
Show More Learn More & Join Trial
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus PHASE3 The trial's objective is to evaluate the immunogenicity of repeated single ...
Show More Learn More & Join Trial